TRCT
SZYM

Tower Research Capital (TRC)’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Tower Research Capital (TRC)’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-353
Closed -$1K – 5478
2016
Q1 		$1K Sell
353
-2,605
-88% -$4.65K ﹤0.01% 3970
2015
Q4 		$7K Sell
2,958
-5,442
-65% -$16.1K ﹤0.01% 2697
2015
Q3 		$22K Buy
8,400
+8,200
+4,100% +$21.4K ﹤0.01% 1671
2015
Q2 		$1K Sell
200
-650
-76% -$2.23K ﹤0.01% 4206
2015
Q1 		$2K Sell
850
-15,267
-95% -$39K ﹤0.01% 3932
2014
Q4 		$42K Buy
16,117
+16,016
+15,857% +$70.1K ﹤0.01% 1141
2014
Q3 		$1K Sell
101
-9,301
-99% -$86.9K ﹤0.01% 4274
2014
Q2 		$111K Buy
+9,402
New +$100K 0.01% 853
2014
Q1 		– Sell
-6,171
Closed -$68K – 5331
2013
Q4 		$68K Buy
6,171
+1,589
+35% +$15.6K 0.01% 1139
2013
Q3 		$50K Buy
4,582
+3,036
+196% +$34.6K 0.01% 1924
2013
Q2 		$18K Buy
+1,546
New +$15.4K ﹤0.01% 1844

Tower Research Capital (TRC)'s SZYM Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 353 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in SZYM in Q2 2013 and held it in 11 quarters. The position peaked at $111K in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Tower Research Capital (TRC) reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 353 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s SOLAZYME INC COM STK (DE) position peaked at $111K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.